Apolipoprotein E4 targets mitochondria and the mitochondria-associated membrane complex in neuropathology, including

Robert W Mahley1

  • 1Gladstone Institute of Neurological Disease, 1650 Owens Street, San Francisco, CA 94158, USA; Departments of Pathology and Medicine, University of California, San Francisco, CA 94143, USA.

Insights

Apolipoprotein E4 (apoE4) impairs brain cell mitochondria, leading to Alzheimer's disease (AD) neuropathology by disrupting energy production and cellular repair mechanisms.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Apolipoprotein E4 (apoE4) is a major genetic risk factor for Alzheimer's disease (AD).
  • Mitochondrial dysfunction and altered mitochondria-associated membranes are implicated in AD pathogenesis.
  • Aberrant contact between mitochondrial and endoplasmic reticulum membranes is observed in AD brain cells.

Purpose of the Study:

  • To investigate the impact of apoE4 on mitochondrial function and mitochondria-associated membranes in neurons.
  • To elucidate the molecular mechanisms by which apoE4 contributes to neuropathology.

Main Methods:

  • Comparative analysis of apoE4-expressing neurons versus controls.
  • Assessment of NAD+/NADH ratio, reactive oxygen species (ROS) levels, and redox protein expression.
  • Evaluation of mitochondrial respiratory complex subunit levels and assembly.
  • Analysis of mitochondrial proteases and translocase levels.

Main Results:

  • ApoE4 expression in neurons leads to increased contact and apposition of mitochondria-endoplasmic reticulum membranes.
  • ApoE4 neurons exhibit a lowered NAD+/NADH ratio, increased ROS, and decreased NAD/NADH pathway components.
  • Impaired oxidative phosphorylation, reduced ATP generation capacity, and decreased respiratory complex subunits were observed in apoE4 neurons.
  • Alterations in mitochondrial cristae organizing system subunits and increased mitochondrial proteases were associated with apoE4.

Conclusions:

  • ApoE4 initiates neuropathology in Alzheimer's disease by causing significant mitochondrial dysfunction.
  • Altered mitochondria-associated membranes and impaired respiratory complex assembly are key mechanisms driven by apoE4.
  • Targeting apoE4-mediated mitochondrial defects may offer therapeutic strategies for Alzheimer's disease.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
594
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
237
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.2K